● Recruiting

Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients

Condition: Pediatric Chronic Inflammatory Demyelinating Polyneuropathy · Sponsor: Octapharma

PhasePhase 3

Planned participants30

Who can joinAll sexes, 2 Years to 17 Years

Healthy volunteersNo

About this study

Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients

This description comes directly from the study's public registry record.

Talk to the study team

Patrick Murphy · 866-337-1868 · ctgov@clinicalresearchmgt.com

Always discuss trial participation with your own doctor first.

Locations (6)

Octapharma Research Site	Birmingham, Alabama, United States	Recruiting
Octapharma Research Site	Orange, California, United States	Recruiting
Octapharma Research Site	Louisville, Kentucky, United States	Recruiting
Octapharma Research Site	Philadelphia, Pennsylvania, United States	Recruiting
Octapharma Research Site	Houston, Texas, United States	Recruiting
Octapharma Research Site	Charlottesville, Virginia, United States	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04929236